INCPF Stock: InnoCare Pharma Limited Stock Price, Analysis & Insights
Get live INCPF stock price $1.55, comprehensive InnoCare Pharma Limited stock analysis, charts, news, and expert forecast. Real-time INCPF stock data and investment insights.
Loading chart data...
InnoCare Pharma Limited (INCPF) Overview
InnoCare Pharma Limited (INCPF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, INCPF trades at $1.55 with a market capitalization of 2.32B . Over the past 52 weeks, INCPF has traded between $1.55 and $3.26 , with the current price positioned at approximately 0% of this range . The stock currently trades ...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 2.32B
- Current price: $1.55
- 52-week range: $1.55 - $3.26
- P/E ratio: 25.83
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
InnoCare Pharma Limited is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments, primarily targeting cancer and autoimmune disorders. A key product in their portfolio is Orelabrutinib, a ...
Company Information
- CEO
- Jisong Cui
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1089
Contact Information
- Address
- Building 8
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 25.8)
✓ Lower volatility stock (Beta: 0.33) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for InnoCare Pharma Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for InnoCare Pharma Limited
- ⚠Investors should consider how InnoCare Pharma Limited fits within their overall portfolio allocation
Market Cap
2.32B
P/E Ratio (TTM)
25.83
Beta
0.33
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare INCPF with peer companies:
- Price
- $38.89
- Market cap
- 7.83B
- Price
- $58.00
- Market cap
- 3.45B
- Price
- $28.38
- Market cap
- 3.32B
- Price
- $37.06
- Market cap
- 2.94B
- Price
- $9.94
- Market cap
- 4.17B
- Price
- $24.85
- Market cap
- 4.54B
- Price
- $1.60
- Market cap
- 3.50B
- Price
- $90.61
- Market cap
- 4.63B
- Price
- $3.35
- Market cap
- 4.84B
- Price
- $43.66
- Market cap
- 3.09B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.